Clinical trials
Multiple Endocrine Neoplasia Type 1 trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Hospital for Sick Children | 6 |
| Laval University | 2 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Joan Bottorff | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| McMaster University | 1 |
| University of British Columbia | 1 |
| University of Calgary | 1 |
| University of New Brunswick | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 17 |
| Obesity | 3 |
| Cardiovascular Diseases | 2 |
| Overweight | 2 |
| Prostatic Neoplasms | 2 |
| Chronic Disease | 1 |
| Insulin Resistance | 1 |
| Muscular Atrophy | 1 |
| Neoplasms | 1 |
| Osteoporosis | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.